Evidence map›Paper›PMID 31483098›Full record

ArticleCurrent protocols in chemical biology2019

Genetic Engineering by DNA Recombineering.

Louis J Papa, Matthew D Shoulders

Open access · bronzeAbstract read
In one paragraph

Article in Current protocols in chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Louis J PapaMassachusetts Institute of Technology, Department of Chemistry, Cambridge, Massachusetts.
Matthew D ShouldersMassachusetts Institute of Technology, Department of Chemistry, Cambridge, Massachusetts.
Massachusetts Institute of Technology · US

Funding

Continuous Directed Evolution of Biomolecules in Human Cells for Medical ResearchDP2GM119162 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2015 to 2015
$2.3M
Defining and Modulating Mechanisms of Collagen ProteostasisR01AR071443 · NIAMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2017 to 2021
$1.7M
NIAMS NIH HHS R01 AR071443NIGMS NIH HHS DP2 GM119162
6 · The paper itself

Abstract

Recombineering inserts PCR products into DNA using homologous recombination. A pair of short homology arms (50 base pairs) on the ends of a PCR cassette target the cassette to its intended location. These homology arms can be easily introduced as 5' primer overhangs during the PCR reaction. The flexibility to choose almost any pair of homology arms enables the precise modification of virtually any DNA for purposes of sequence deletion, replacement, insertion, or point mutation. Recombineering often offers significant advantages relative to previous homologous recombination methods that require the construction of cassettes with large homology arms, and relative to traditional cloning methods that become intractable for large plasmids or DNA sequences. However, the tremendous number of variables, options, and pitfalls that can be encountered when designing and performing a recombineering protocol for the first time introduce barriers that can make recombineering a challenging technique for new users to adopt. This article focuses on three recombineering protocols we have found to be particularly robust, providing a detailed guide for choosing the simplest recombineering method for a given application and for performing and troubleshooting experiments. © 2019 by John Wiley & Sons, Inc.

Indexed as

DNAEscherichia coliGene DeletionGenetic EngineeringMutagenesis, InsertionalPlasmidsPoint MutationPolymerase Chain ReactionResearch DesignDNAEscherichia coligenetic engineeringhomologous recombinationrecombineeringviral genome engineering

Identifiers

PMID31483098
PMCPMC6727988
OpenAlexW2954306926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.